Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials

Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults

(2020) Oriol Grau-Rivera et al.   Alzheimers Research & Therapy

Circadian and sleep dysfunction in Alzheimer’s disease

(2020) Md. Sahab Uddin et al.   AGEING RESEARCH REVIEWS

Protective Effects of Melatonin against Severe Burn-Induced Distant Organ Injury: A Systematic Review and Meta-Analysis of Experimental Studies

(2020) Dewan Md. Sumsuzzman et al.   Antioxidants

Roles of aging in sleep

(2019) Hua-Hua Zhong et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Daytime melatonin and light independently affect human alertness and body temperature

(2019) Renske Lok et al.   JOURNAL OF PINEAL RESEARCH

Pharmacological doses of melatonin impede cognitive decline in tau‐related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux

(2019) Enrique Luengo et al.   JOURNAL OF PINEAL RESEARCH

The assessment and management of insomnia: an update

(2019) Andrew D. Krystal et al.   World Psychiatry

Comparison of the Effects of Melatonin and Oxazepam on Anxiety Levels and Sleep Quality in Patients With ST-Segment-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial

(2018) Padideh Ghaeli et al.   ANNALS OF PHARMACOTHERAPY

The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review

(2018) Jacqueline K. Kueper et al.   JOURNAL OF ALZHEIMERS DISEASE

Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives

(2018) Jeffrey Guina et al.   Journal of Clinical Medicine

Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer’s disease and schizophrenia: Insights from studies in patient populations and animal models

(2018) Raphaelle Winsky-Sommerer et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The neurocognitive consequences of sleep restriction: A meta-analytic review

(2017) Cassandra J. Lowe et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers

(2016) Zahid Sadek Chowdhury et al.   BEHAVIOURAL NEUROLOGY

Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease

(2016) Yuan-Yuan Wang et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study

(2016) Shelly L Gray et al.   BMJ-British Medical Journal

Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study

(2016) Shelly L Gray et al.   BMJ-British Medical Journal

Melatonin for Sleep Disorders and Cognition in Dementia

(2015) Jing Xu et al.   American Journal of Alzheimers Disease and Other Dementias

Impact of sleep on the risk of cognitive decline and dementia

(2014) Adam P. Spira et al.   CURRENT OPINION IN PSYCHIATRY

Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls

(2014) Joanna Rybka et al.   DRUG DELIVERY

Cognitive Impairment in Individuals with Insomnia: Clinical Significance and Correlates

(2014) Émilie Fortier-Brochu et al.   SLEEP

Normal Cognitive Aging

(2013) Caroline N. Harada et al.   CLINICS IN GERIATRIC MEDICINE

Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders

(2013) Eduardo Ferracioli-Oda et al.   PLoS One

Sleep Drives Metabolite Clearance from the Adult Brain

(2013) L. Xie et al.   SCIENCE

A 10-year trend of insomnia prevalence in the adult Norwegian population

(2013) Ståle Pallesen et al.   SLEEP MEDICINE

Putting the Alzheimer’s cognitive test to the test I: Traditional psychometric methods

(2012) Jeremy Hobart et al.   Alzheimers & Dementia

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries

(2012) Emilie Clay et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia

(2012) Patrick Lemoine et al.   EXPERT OPINION ON PHARMACOTHERAPY

Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance

(2012) Stephanie J. Crowley et al.   PSYCHOPHARMACOLOGY

Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database

(2011) Francois Chavant et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

GREATER RISK OF ALZHEIMER'S DISEASE IN OLDER ADULTS WITH INSOMNIA

(2011) Ricardo S. Osorio et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

(2010) Alan G. Wade et al.   CURRENT MEDICAL RESEARCH AND OPINION

Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease

(2009) Philip R. Gehrman et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

The Association Between Dementia and Long-Term Use of Benzodiazepine in the Elderly: Nested Case–Control Study Using Claims Data

(2009) Chi-Shin Wu et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

(2009) Remy Luthringer et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem

(2009) TIM R. M. LEUFKENS et al.   JOURNAL OF SLEEP RESEARCH

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

(2008) S. Otmani et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities

(2008) Rixt F. Riemersma-van der Lek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Melatonin and Bright-Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's Disease

(2008) Glenna A. Dowling et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY